BioGeneration III Services BV
Gooimeer 2-35
1411DC Naarden
NL
BioGeneration III Services BV
Foundation date
10/11/2006
Sector
#InvestorSubsector
BioGeneration Ventures (BGV) is a venture capital company, with a focus on early stage European biotech companies. The Company has a strong track record of significant financial returns through investing in innovations in healthcare and providing the expertise to build world-class teams. The Company manages over €250 million ($300 million) of funds investing in areas where true scientific innovations, the unmet medical need, and the potential to demonstrate a significant proof of concept all come together.
BGV strives to work with founding teams to mature science and build companies. The Company uses its experience to guide progress into clinical trials, ultimately leading to successful drug development and value realisation for its investors. BGV applies its expertise in a rigorous process to select the most compelling opportunities with the best prospects for exit.
Upcoming events
All events-
1605 '24
Knowledge for Growth 2024
Event by: flanders.bio -
1505 '24
State of the Union by VIB & flanders.bio
Event by: flanders.bio & VIB -
2105 '24
IOT Solutions World Congress 2024
Event by: Fira Barcelona
Latest news
More news-
Biotalys Appoints Laura J. Meyer to Board of Directors
Tuesday April 30th 2024
Read more
-
V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors
Wednesday April 24th 2024
Read more
-
Labconsort and NEKTARI join forces for a more sustainable and social industry
Saturday April 20th 2024
Read more
Jobs
More jobs-
-
30/04/24
East Flanders
Marie-Curie (MSCA) doctoral fellowship: PhD in Structural Dynamics and SHM (ref. BAP-2024-245)
Temporary
KU Leuven -
More info?
Ellen Telleir
Communication Coordinator